To Establish Whether Dapagliflozin and Spironolactone in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement, Result in Better Left Ventricular Mass Regression, Myocardial Health and Patient Reported Outcomes
Clinical trial NCT07539259 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07539259
- Sponsor
- University College, London
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2029-08-01
- Enrollment
- 445
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.